Ambrosia Biosciences

Ambrosia Biosciences

CO - Boulder
Biotechnology

Focus: Oral Small Molecules - Class B GPCRs

Ambrosia Biosciences is a life sciences company focused on Oral Small Molecules - Class B GPCRs.

Gastroenterology
Funding Stage
PUBLIC
Total Funding
$130M
Open Jobs
0

Pipeline & Clinical Trials

Probiotics-Bio-plus
Liver Cirrhosis
N/A
Clinical Trials (1)
NCT00312910Probiotics for the Prevention of Major Complications of Cirrhosis
N/A
Solgar No7 Complex
Osteoarthritis, Knee
N/A
Clinical Trials (1)
NCT03442153Comparative Efficacy and Tolerability of No7 in Osteoarthritis of the Knee
N/A
Plasma
Aging
N/A
Clinical Trials (1)
NCT02803554Young Donor Plasma Transfusion and Age-Related Biomarkers
N/A
Clinical Trials (1)
NCT01593800The Effect of Probiotics on Lactose Intolerance
N/A
Probiotic Arm
Constipation
Phase 4
Clinical Trials (1)
NCT06959758Effects of Probiotics (BioKid LR - Contains Nine Different Species of Probiotics Bacteria Including L. Reuteri) in Children With Functional Constipation
Phase 4

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Founded: 2018
Portfolio: 5 clinical trials